<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36998202</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1933-690X</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Prion</Title><ISOAbbreviation>Prion</ISOAbbreviation></Journal><ArticleTitle>Viruses and amyloids - a vicious liaison.</ArticleTitle><Pagination><StartPage>82</StartPage><EndPage>104</EndPage><MedlinePgn>82-104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/19336896.2023.2194212</ELocationID><Abstract><AbstractText>The crosstalk between viral infections, amyloid formation and neurodegeneration has been discussed with varying intensity since the last century. Several viral proteins are known to be amyloidogenic. Post-acute sequalae (PAS) of viral infections is known for several viruses. SARS-CoV-2 and COVID-19 implicate connections between amyloid formation and severe outcomes in the acute infection, PAS and neurodegenerative diseases. Is the amyloid connection causation or just correlation? In this review we highlight several aspects where amyloids and viruses meet. The evolutionary driving forces that dictate protein amyloid formation propensity are different for viruses compared to prokaryotes and eukaryotes, while posttranslational endoproteolysis appears to be a common mechanism leading up to amyloid formation for both viral and human proteins. Not only do human and viral proteins form amyloid irrespective of each other but there are also several examples of co-operativity between amyloids, viruses and the inter-, and intra-host spread of the respective entity. Abnormal blood clotting in severe and long COVID and as a side effect in some vaccine recipients has been connected to amyloid formation of both the human fibrin and the viral Spike-protein. We conclude that there are many intersects between viruses and amyloids and, consequently, amyloid and virus research need to join forces here. We emphasize the need to accelerate development and implementation in clinical practice of antiviral drugs to preclude PAS and downstream neurological damage. There is also an ample need for retake on suitable antigen targets for the further development of next generation of vaccines against the current and coming pandemics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hammarstr&#xf6;m</LastName><ForeName>Per</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5827-3587</Identifier><AffiliationInfo><Affiliation>IFM-Chemistry, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nystr&#xf6;m</LastName><ForeName>Sofie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4303-4783</Identifier><AffiliationInfo><Affiliation>IFM-Chemistry, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Prion</MedlineTA><NlmUniqueID>101472305</NlmUniqueID><ISSNLinking>1933-6896</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyloid</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute sequalae COVID-19</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36998202</ArticleId><ArticleId IdType="pmc">PMC10072076</ArticleId><ArticleId IdType="doi">10.1080/19336896.2023.2194212</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Choutka J, Jansari V, Hornig M, et al. Unexplained post-acute infection syndromes. Nature Med. 2022. May 01;28(5):911&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine KS, Leonard HL, Blauwendraat C, et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron. 2023. Jan 11. DOI:10.1016/j.neuron.2022.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.12.029</ArticleId><ArticleId IdType="pmc">PMC10079561</ArticleId><ArticleId IdType="pubmed">36669485</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanwar A, Selvaraju S, Esper F.. Human coronavirus-HKU1 infection among adults in Cleveland, Ohio. Open Forum Infect Dis. 2017;4(2):ofx052. Spring. 10.1093/ofid/ofx052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofx052</ArticleId><ArticleId IdType="pmc">PMC5466428</ArticleId><ArticleId IdType="pubmed">28616442</ArticleId></ArticleIdList></Reference><Reference><Citation>Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013. Sep;13(9):752&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185445</ArticleId><ArticleId IdType="pubmed">23891402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadman M, Couzin-Frankel J, Kaiser J, et al. A rampage through the body. Science. 2020. Apr 24;368(6489):356&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">32327580</ArticleId></ArticleIdList></Reference><Reference><Citation>Elezkurtaj S, Greuel S, Ihlow J, et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci Rep. 2021. Feb 19;11(1):4263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7895917</ArticleId><ArticleId IdType="pubmed">33608563</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb BJ, Peltan ID, Jensen P, et al. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol. 2020. Dec;2(12):e754&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7524533</ArticleId><ArticleId IdType="pubmed">33015645</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nature Med. 2020. Jul 01;26(7):1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, L&#xfc;tgehetmann M, Lindenmeyer MT, et al. Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med. 2020. Aug 06;383(6):590&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F, Qian S, Zhang S, et al. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020. May 21;526(1):135&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156119</ArticleId><ArticleId IdType="pubmed">32199615</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahranavard M, Akhavan Rezayat A, Zamiri Bidary M, et al. Cardiac complications in COVID-19: a systematic review and meta-analysis. Arch Iran Med. 2021. Feb 1;24(2):152&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">33636985</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra S, Kolappa K, Prasad M, et al. Frequency of neurologic manifestations in COVID-19. Neurology. 2021;97(23):e2269. DOI:10.1212/WNL.0000000000012930</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012930</ArticleId><ArticleId IdType="pmc">PMC8665434</ArticleId><ArticleId IdType="pubmed">34635561</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020. Jul 01;98(1):209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229463</ArticleId><ArticleId IdType="pubmed">32416116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao R, Qiu Y, J-S H, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020. Jul 01;5(7):667&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217643</ArticleId><ArticleId IdType="pubmed">32405603</ArticleId></ArticleIdList></Reference><Reference><Citation>Drucker DJ. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metab. 2021. Mar 2;33(3):479&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7825982</ArticleId><ArticleId IdType="pubmed">33529600</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazartigues E, Qadir M, Mauvais-Jarvis F. Endocrine Significance of SARS-CoV-2&#x2019;s Reliance on ACE2. Endocrinology. 2020;161(9):bqaa108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454499</ArticleId><ArticleId IdType="pubmed">32652001</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke SA, Abbara A, Dhillo WS. Impact of COVID-19 on the endocrine system: a mini-review. Endocrinology. 2022;163(1):bqab203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500009</ArticleId><ArticleId IdType="pubmed">34543404</ArticleId></ArticleIdList></Reference><Reference><Citation>Morissette G, Flamand L. Herpesviruses and chromosomal integration. J Virol. 2010;84(23):12100&#x2013;12109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2976420</ArticleId><ArticleId IdType="pubmed">20844040</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarleri J. Poliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus. Geroscience. 2023. Apr 01;45(2):707&#x2013;717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9886775</ArticleId><ArticleId IdType="pubmed">36260265</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeye RL, Blanc W. Pathogenesis of congenital rubella. JAMA. 1965;194(12):1277&#x2013;1283.</Citation><ArticleIdList><ArticleId IdType="pubmed">5898080</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschenberger M, Hunszinger V, Sparrer KMJ. Implications of innate immunity in post-acute sequelae of non-persistent viral infections. Cells. 2021. Aug 19;10(8):2134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8391718</ArticleId><ArticleId IdType="pubmed">34440903</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med (Lond). 2021. Jan;21(1):e68&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>Das KM, Lee EY, Singh R, et al. Follow-up chest radiographic findings in patients with MERS-Cov after recovery. Indian J Radiol Imaging. 2017. Jul-Sep;27(3):342&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5644332</ArticleId><ArticleId IdType="pubmed">29089687</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DS, Wong KT, Antonio GE, et al. Long-term sequelae of SARS: physical, neuropsychiatric, and quality-of-life assessment. Hong Kong Med J. 2009. Dec;15(Suppl 8):21&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">20393208</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Li J, Liu H, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020;8(1):8. DOI:10.1038/s41413-020-0084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41413-020-0084-5</ArticleId><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam M-B, Wing Y-K, MW-M Y, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Internal Med. 2009;169(22):2142&#x2013;2147. DOI:10.1001/archinternmed.2009.384</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Shin HS, Park HY, et al. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in Middle East respiratory syndrome survivors. Psychiatry Investig. 2019. Jan;16(1):59&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6354037</ArticleId><ArticleId IdType="pubmed">30605995</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F, Belati A, Tulone O, et al. Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients. Intern Emerg Med. 2022. Nov;30:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9709360</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxbaum JN, Dispenzieri A, Eisenberg DS, et al. Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2022. Nov;29(4):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">36420821</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. Long COVID: major findings, mechanisms and recommendations. Nature Rev Microbiol. 2023. March 01;21(3):133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubel MS, Fedotov SA, Grizel AV, et al. Functional mammalian amyloids and amyloid-like proteins. Life (Basel). 2020. Aug 21;10(9):156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7555005</ArticleId><ArticleId IdType="pubmed">32825636</ArticleId></ArticleIdList></Reference><Reference><Citation>Maji SK, Perrin MH, Sawaya MR, et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science. 2009. Jul 17;325(5938):328&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2865899</ArticleId><ArticleId IdType="pubmed">19541956</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewetson A, Do HQ, Myers C, et al. Functional amyloids in reproduction. Biomolecules. 2017. Jun 29;7(4):46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5618227</ArticleId><ArticleId IdType="pubmed">28661450</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunger AF, Nienhuis HLA, Bijzet J, et al. Causes of AA amyloidosis: a systematic review. Amyloid. 2020. Mar;27(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">31766892</ArticleId></ArticleIdList></Reference><Reference><Citation>Sori&#x107; Hosman I, Kos I, Lamot L. Serum amyloid a in inflammatory rheumatic diseases: a compendious review of a renowned biomarker [Review]. Front Immunol. 2021. Feb 19;11:631299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7933664</ArticleId><ArticleId IdType="pubmed">33679725</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol. 2017. Aug;36(8):1707&#x2013;1713.</Citation><ArticleIdList><ArticleId IdType="pubmed">28624931</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateishi Y, Yamada Y, Katsuki M, et al. Pathological review of cardiac amyloidosis using autopsy cases in a single Japanese institution. Pathol Res Pract. 2021. Nov;227:153635.</Citation><ArticleIdList><ArticleId IdType="pubmed">34653913</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisel JW, Litvinov RI. Fibrin formation, structure and properties. Subcell Biochem. 2017;82:405&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536120</ArticleId><ArticleId IdType="pubmed">28101869</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson MD, Liepnieks J, Uemichi T, et al. Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain. Nat Genet. 1993. Mar;3(3):252&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">8097946</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman J, Dogan A. Fibrinogen alpha amyloidosis: insights from proteomics. Expert Rev Proteomics. 2019. Sep;16(9):783&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6788741</ArticleId><ArticleId IdType="pubmed">31443619</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnier C, Briki F, Nedelec B, et al. VLITL is a major cross-beta-sheet signal for fibrinogen Aalpha-chain frameshift variants. Blood. 2017. Dec 21;130(25):2799&#x2013;2807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5843806</ArticleId><ArticleId IdType="pubmed">29089309</ArticleId></ArticleIdList></Reference><Reference><Citation>Kranenburg O, Bouma B, Kroon-Batenburg LM, et al. Tissue-type plasminogen activator is a multiligand cross-beta structure receptor. Curr Biol. 2002. Oct 29;12(21):1833&#x2013;1839.</Citation><ArticleIdList><ArticleId IdType="pubmed">12419183</ArticleId></ArticleIdList></Reference><Reference><Citation>Liz MA, Coelho T, Bellotti V, et al. A narrative review of the role of transthyretin in health and disease. Neurol Ther. 2020. Dec;9(2):395&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606379</ArticleId><ArticleId IdType="pubmed">33001386</ArticleId></ArticleIdList></Reference><Reference><Citation>Milardi D, Gazit E, Radford SE, et al. Proteostasis of islet amyloid polypeptide: a molecular perspective of risk factors and protective strategies for type II diabetes. Chem Rev. 2021. Feb 10;121(3):1845&#x2013;1893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10317076</ArticleId><ArticleId IdType="pubmed">33427465</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer&#x2019;s disease. Lancet. 2021. Apr 24;397(10284):1577&#x2013;1590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354300</ArticleId><ArticleId IdType="pubmed">33667416</ArticleId></ArticleIdList></Reference><Reference><Citation>Collinge J. Mammalian prions and their wider relevance in neurodegenerative diseases. Nature. 2016. Nov 01;539(7628):217&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">27830781</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghammer P, Just MK, Horsager J, et al. A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson&#x2019;s disease. NPJ Parkinsons Dis. 2022. Nov 30;8(1):166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9712280</ArticleId><ArticleId IdType="pubmed">36450732</ArticleId></ArticleIdList></Reference><Reference><Citation>Abeliovich A, Gitler AD. Defects in trafficking bridge Parkinson&#x2019;s disease pathology and genetics. Nature. 2016. Nov 10;539(7628):207&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">27830778</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S, Goizet C, Soulages A, et al. Genetics of amyotrophic lateral sclerosis: a review. J Neurol Sci. 2019. Apr 15;399:217&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonfelder J, Pfeiffer PB, Pradhan T, et al. Protease resistance of ex vivo amyloid fibrils implies the proteolytic selection of disease-associated fibril morphologies. Amyloid. 2021. Dec;28(4):243&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">34338090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangione PP, Verona G, Corazza A, et al. Plasminogen activation triggers transthyretin amyloidogenesis in vitro. J Biol Chem. 2018. Sep 14;293(37):14192&#x2013;14199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6139548</ArticleId><ArticleId IdType="pubmed">30018138</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T, Liepnieks JJ, Kluve-Beckerman B, et al. Cathepsin B generates the most common form of amyloid a (76 Residues) as a degradation product from serum amyloid a 10.1111/j.1365-3083.1995.Tb03538.x. Scand J Immunol. 1995. Jan 01;41(1)):94&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.1995.Tb03538.x</ArticleId><ArticleId IdType="pubmed">7824894</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman SL, Cathcart ES, Skinner M, et al. The degradation of serum amyloid a protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase. Immunology. 1982. Aug;46(4):737&#x2013;744.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1555477</ArticleId><ArticleId IdType="pubmed">6921153</ArticleId></ArticleIdList></Reference><Reference><Citation>Garringer HJ, Murrell J, D&#x2019;adamio L, et al. Modeling familial British and Danish dementia. Brain Struct Funct. 2010. Mar;214(2&#x2013;3):235&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8375673</ArticleId><ArticleId IdType="pubmed">19779737</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon JP, Page LJ, Balch WE, et al. Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Crit Rev Biochem Mol Biol. 2012. May-Jun;47(3):282&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3337338</ArticleId><ArticleId IdType="pubmed">22360545</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky VN, Fink AL. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta. 2004. May 6;1698(2):131&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">15134647</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseau F, Serrano L, Schymkowitz JW. How evolutionary pressure against protein aggregation shaped chaperone specificity. J Mol Biol. 2006. Feb 3;355(5):1037&#x2013;1047.</Citation><ArticleIdList><ArticleId IdType="pubmed">16359707</ArticleId></ArticleIdList></Reference><Reference><Citation>Beerten J, Jonckheere W, Rudyak S, et al. Aggregation gatekeepers modulate protein homeostasis of aggregating sequences and affect bacterial fitness. Protein Eng Des Sel. 2012. Jul;25(7):357&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">22706763</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammarstrom P, Jiang X, Hurshman AR, et al. Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc Natl Acad Sci U S A. 2002. Dec 10;4(Suppl 4):16427&#x2013;16432. 99 Suppl.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC139904</ArticleId><ArticleId IdType="pubmed">12351683</ArticleId></ArticleIdList></Reference><Reference><Citation>Mead S. Prion disease genetics. Eur J Hum Genet. 2006. Mar;14(3):273&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">16391566</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson JS, Richardson DC. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci U S A. 2002. Mar 5;99(5):2754&#x2013;2759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122420</ArticleId><ArticleId IdType="pubmed">11880627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright CF, Teichmann SA, Clarke J, et al. The importance of sequence diversity in the aggregation and evolution of proteins. Nature. 2005. Dec 8;438(7069):878&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pubmed">16341018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadibalban AS, Bogumil D, Landan G, et al. DnaK-Dependent accelerated evolutionary rate in prokaryotes. Genome Biol Evol. 2016. Jun 3;8(5):1590&#x2013;1599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4898814</ArticleId><ArticleId IdType="pubmed">27189986</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Ponce D, Aguilar-Rodriguez J, Fares MA. Molecular chaperones accelerate the evolution of their protein clients in Yeast. Genome Biol Evol. 2019. Aug 1;11(8):2360&#x2013;2375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735891</ArticleId><ArticleId IdType="pubmed">31297528</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachowiec J, Lemus T, Borenstein E, et al. Hsp90 promotes kinase evolution. Mol Biol Evol. 2015. Jan;32(1):91&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4271522</ArticleId><ArticleId IdType="pubmed">25246701</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartaglia GG, Pechmann S, Dobson CM, et al. Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci. 2007. May;32(5):204&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">17419062</ArticleId></ArticleIdList></Reference><Reference><Citation>Santra M, Dill KA, de Graff Amr, et al. Proteostasis collapse is a driver of cell aging and death. Proc Natl Acad Sci U S A. 2019. Oct 29;116(44):22173&#x2013;22178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6825304</ArticleId><ArticleId IdType="pubmed">31619571</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma K, Verma M, Chaphalkar A, et al. Recent advances in understanding the role of proteostasis. Fac Rev. 2021. ;10:72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8483240</ArticleId><ArticleId IdType="pubmed">34632458</ArticleId></ArticleIdList></Reference><Reference><Citation>Milo R, Phillips R. Cell biology by the numbers. New York, NY: Garland Science, Taylor &amp; Francis Group; 2016.</Citation></Reference><Reference><Citation>Firth AE, Brierley I. Non-canonical translation in RNA viruses. J Gen Virol. 2012. Jul;93(Pt 7):1385&#x2013;1409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3542737</ArticleId><ArticleId IdType="pubmed">22535777</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu MG. Assembly, stability and dynamics of virus capsids. Arch Biochem Biophys. 2013. Mar;531(1&#x2013;2):65&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">23142681</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman MS, Liljas L. Structural folds of viral proteins. Adv Protein Chem. 2003;64:125&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">13677047</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevvana M, Klose T, Rossmann MG. Principles of virus structure. In: Bamford D, Zuckerman M, editors. Encyclopedia of virology. Fourth ed. Oxford: Academic Press; 2021. pp. 257&#x2013;277.</Citation></Reference><Reference><Citation>Langenberg T, Gallardo R, van der Kant R, et al. Thermodynamic and evolutionary coupling between the native and amyloid state of Globular proteins. Cell Rep. 2020. Apr 14;31(2):107512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175379</ArticleId><ArticleId IdType="pubmed">32294448</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JE. Virus particle dynamics. Adv Protein Chem. 2003;64:197&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pubmed">13677048</ArticleId></ArticleIdList></Reference><Reference><Citation>Canady MA, Tihova M, Hanzlik TN, et al. Large conformational changes in the maturation of a simple RNA virus, nudaurelia capensis omega virus (NomegaV). J Mol Biol. 2000. Jun 9;299(3):573&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pubmed">10835268</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Vies Sm, Gatenby AA, Georgopoulos C, et al. Bacteriophage T4 encodes a co-chaperonin that can substitute for Escherichia coli GroES in protein folding. Nature. 1994. Apr 14;368(6472):654&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pubmed">7908418</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Liu Y, Yang Y, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020. May;10(5):766&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102550</ArticleId><ArticleId IdType="pubmed">32292689</ArticleId></ArticleIdList></Reference><Reference><Citation>Charnley M, Islam S, Bindra GK, et al. Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19. Nat Commun. 2022. Jun 13;13(1):3387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189797</ArticleId><ArticleId IdType="pubmed">35697699</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayeb-Fligelman E, Cheng X, Tai C, et al. Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2. bioRxiv. 2021. Mar 18.</Citation></Reference><Reference><Citation>Nystr&#xf6;m S, Hammarstr&#xf6;m P. Amyloidogenesis of SARS-CoV-2 spike protein. J Am Chem Soc. 2022. May 25;144(20):8945&#x2013;8950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9136918</ArticleId><ArticleId IdType="pubmed">35579205</ArticleId></ArticleIdList></Reference><Reference><Citation>GISAD . hCoV19 variants 2023 [cited
2023. 
Jan
31]. Available from: https://gisaid.org/hcov19-variants/</Citation></Reference><Reference><Citation>Breijyeh Z, Karaman R. Comprehensive review on alzheimer&#x2019;s disease: causes and treatment. Molecules. 2020;25(24):5789. [cited. 10.3390/molecules25245789.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25245789</ArticleId><ArticleId IdType="pmc">PMC7764106</ArticleId><ArticleId IdType="pubmed">33302541</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermark GT, Sletten K, Grubb A, et al. AA-Amyloidosis: tissue complement-specific association of various protein AA subspecies and evidence of a fourth SAA gene product [Article]. Am J Pathol. 1990;137(2):377&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1877615</ArticleId><ArticleId IdType="pubmed">2386201</ArticleId></ArticleIdList></Reference><Reference><Citation>Rennegarbe M, Lenter I, Schierhorn A, et al. Influence of C-terminal truncation of murine Serum amyloid a on fibril structure [Article]. Sci Rep. 2017;7(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5522423</ArticleId><ArticleId IdType="pubmed">28733641</ArticleId></ArticleIdList></Reference><Reference><Citation>Appleby BS, Shetty S, Elkasaby M. Genetic aspects of human prion diseases. Front Neurol. 2022;13:1003056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9579322</ArticleId><ArticleId IdType="pubmed">36277922</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier C, Al Bazzal A, Vidic J, et al. PB1-F2 influenza a virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments. J Biol Chem. 2010. Apr 23;285(17):13233&#x2013;13243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2857135</ArticleId><ArticleId IdType="pubmed">20172856</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier C, Leymarie O, Sedano L, et al. PB1-F2 amyloid-like fibers correlate with proinflammatory signaling and respiratory distress in influenza-infected mice. J Biol Chem. 2021. Jul;297(1):100885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8294585</ArticleId><ArticleId IdType="pubmed">34146545</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaldzhyan AA, Zabrodskaya YA, Baranovskaya IL, et al. Old dog, new tricks: influenza a virus NS1 and in vitro fibrillogenesis. Biochimie. 2021. Nov;190:50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">34273416</ArticleId></ArticleIdList></Reference><Reference><Citation>Health NIo . Guillain-Barr&#xe9; syndrome fact sheet NINDS.NIH.gov: nIH; 2022.  [cited 2022 dec
29]. Available from: https://www.ninds.nih.gov/guillain-barre-syndrome-fact-sheet</Citation></Reference><Reference><Citation>Mohd Ropidi MI, Khazali AS, Nor Rashid N, et al. Endoplasmic reticulum: a focal point of Zika virus infection. J Biomed Sci. 2020. Jan 20;27(1):27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6971992</ArticleId><ArticleId IdType="pubmed">31959174</ArticleId></ArticleIdList></Reference><Reference><Citation>Saumya KU, Gadhave K, Kumar A, et al. Zika virus capsid anchor forms cytotoxic amyloid-like fibrils. Virology. 2021. Aug;560:8&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">34020329</ArticleId></ArticleIdList></Reference><Reference><Citation>Chimelli L, Melo ASO, Avvad-Portari E, et al. The spectrum of neuropathological changes associated with congenital Zika virus infection. Acta Neuropathol. 2017. Jun;133(6):983&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pubmed">28332092</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz LS, Parra B, Pardo CA, et al. Neurological Implications of Zika virus infection in adults. J Infect Dis. 2017. Dec 16;216(suppl_10):S897&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853915</ArticleId><ArticleId IdType="pubmed">29267923</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, Ortega-Sanchez IR, Seward JF, et al. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008. Jun 6;57(RR&#x2013;5):1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">18528318</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson P. Postherpetic neuralgia. Am Fam Physician. 2011. Sep 15;84(6):690&#x2013;692.</Citation><ArticleIdList><ArticleId IdType="pubmed">21916395</ArticleId></ArticleIdList></Reference><Reference><Citation>Becerra JC, Sieber R, Martinetti G, et al. Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis. 2013. Jul;17(7):e529&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">23566589</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology. 2008. Mar 11;70(11):853&#x2013;860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2938740</ArticleId><ArticleId IdType="pubmed">18332343</ArticleId></ArticleIdList></Reference><Reference><Citation>Steain M, Baker M, Pham CLL, et al. Varicella zoster virus encodes a viral decoy RHIM to inhibit cell death. PLOS Pathog. 2020. Jul;16(7):e1008473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7375649</ArticleId><ArticleId IdType="pubmed">32649716</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Herpes simplex virus. Fact sheets: WHO; 2022.</Citation></Reference><Reference><Citation>Croen KD, Ostrove JM, Dragovic LJ, et al. Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene &#x201c;anti-sense&#x201d; transcript by in situ hybridization. N Engl J Med. 1987. Dec 3;317(23):1427&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">2825014</ArticleId></ArticleIdList></Reference><Reference><Citation>McGraw HM, Awasthi S, Wojcechowskyj JA, et al. Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9. J Virol. 2009. Sep;83(17):8315&#x2013;8326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2738194</ArticleId><ArticleId IdType="pubmed">19570876</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee GH, Kim J, Kim HW, et al. Herpes simplex viruses (1 and 2) and varicella-zoster virus infections in an adult population with aseptic meningitis or encephalitis: a nine-year retrospective clinical study. Medicine (Baltimore). 2021. Nov 19;100(46):e27856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8601327</ArticleId><ArticleId IdType="pubmed">34797322</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugam N, Baker M, Sanz-Hernandez M, et al. Herpes simplex virus encoded ICP6 protein forms functional amyloid assemblies with necroptosis-associated host proteins. Biophys Chem. 2021. Feb;269:106524.</Citation><ArticleIdList><ArticleId IdType="pubmed">33348174</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh VK, Kumar S, Tapryal S. Aggregation propensities of herpes simplex virus-1 proteins and derived peptides. An in silico and in vitro Analysis ACS Omega. 2020. Jun 9;5(22):12964&#x2013;12973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7288601</ArticleId><ArticleId IdType="pubmed">32548480</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen VC, Wu SI, Huang KY, et al. Herpes zoster and dementia: a nationwide population-based cohort study. J Clin Psychiatry. 2018. Jan/Feb;79(1):16m11312.</Citation><ArticleIdList><ArticleId IdType="pubmed">29244265</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai M-C, Cheng W-L, Sheu J-J, et al. Increased risk of dementia following herpes zoster ophthalmicus. PLoS ONE. 2017;12(11):e0188490. DOI:10.1371/journal.pone.0188490</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0188490</ArticleId><ArticleId IdType="pmc">PMC5699837</ArticleId><ArticleId IdType="pubmed">29166672</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzeng N-S, Chung C-H, Lin F-H, et al. Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections&#x2014;a nationwide, population-based cohort study in Taiwan. Neurotherapeutics. 2018. Apr 01;15(2):417&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935641</ArticleId><ArticleId IdType="pubmed">29488144</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S, Yun S-C, Kim M-C, et al. Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur Arch Psychiatry Clin Neurosci. 2021. Aug 01;271(5):987&#x2013;997.</Citation><ArticleIdList><ArticleId IdType="pubmed">32613564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopatko Lindman K, Hemmingsson E-S, Weidung B, et al. Herpesvirus infections, antiviral treatment, and the risk of dementia&#x2014;a registry-based cohort study in Sweden. Alzheimer&#x2019;s &amp; Dementia: Transl Res Clin Interventions. 2021. Jan 01;7(1):e12119. 10.1002/trc2.12119</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12119</ArticleId><ArticleId IdType="pmc">PMC7882534</ArticleId><ArticleId IdType="pubmed">33614892</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak MA, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within Alzheimer&#x2019;s disease amyloid plaques. J Pathol. 2009. Jan;217(1):131&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">18973185</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzat K, Pernemalm M, P&#xe5;lsson S, et al. The viral protein corona directs viral pathogenesis and amyloid aggregation. Nat Commun. 2019. May 27;10(1):2331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536551</ArticleId><ArticleId IdType="pubmed">31133680</ArticleId></ArticleIdList></Reference><Reference><Citation>Christ W, Kapell S, Mermelekas G, et al. SARS-CoV-2 and HSV-1 induce amyloid aggregation in human CSF. bioRxiv. 2022. Sep 15. 508120.</Citation></Reference><Reference><Citation>Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis. 2013. Nov;13(11):976&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4108270</ArticleId><ArticleId IdType="pubmed">24156898</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulop T, Witkowski JM, Larbi A, et al. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer&#x2019;s disease? J Neurovirol. 2019. Oct;25(5):634&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pubmed">30868421</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeinolabediny Y, Caccuri F, Colombo L, et al. HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders. Sci Rep. 2017. Sep 4;7(1):10313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5583282</ArticleId><ArticleId IdType="pubmed">28871125</ArticleId></ArticleIdList></Reference><Reference><Citation>Joly V, Jidar K, Tatay M, et al. Enfuvirtide: from basic investigations to current clinical use. Expert Opin Pharmacother. 2010. Nov;11(16):2701&#x2013;2713.</Citation><ArticleIdList><ArticleId IdType="pubmed">20977403</ArticleId></ArticleIdList></Reference><Reference><Citation>Naujokas A, Vidal CI, Mercer SE, et al. A novel form of amyloid deposited at the site of enfuvirtide injection. J Cutan Pathol. 2012. Feb;39(2):220&#x2013;221. quiz 219. DOI:10.1111/j.1600-0560.2012.01865_2.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0560.2012.01865_2.x</ArticleId><ArticleId IdType="pubmed">22264247</ArticleId></ArticleIdList></Reference><Reference><Citation>Michiels E, Rousseau F, Schymkowitz J. Mechanisms and therapeutic potential of interactions between human amyloids and viruses. Cell Mol Life Sci. 2021. Mar 01;78(6):2485&#x2013;2501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7690653</ArticleId><ArticleId IdType="pubmed">33244624</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch J, Rucker E, Standker L, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell. 2007. Dec 14;131(6):1059&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pubmed">18083097</ArticleId></ArticleIdList></Reference><Reference><Citation>Roan NR, M&#xfc;ller JA, Liu H, et al. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host &amp; Microbe. 2011. Dec 15;10(6):541&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3257029</ArticleId><ArticleId IdType="pubmed">22177559</ArticleId></ArticleIdList></Reference><Reference><Citation>Roan NR, Sandi-Monroy N, Kohgadai N, et al. Semen amyloids participate in spermatozoa selection and clearance. Elife. 2017. Jun 27;6:e24888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5487211</ArticleId><ArticleId IdType="pubmed">28653619</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorson A, Formenty P, Lofthouse C, et al. Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations. BMJ Open. 2016. Jan 7;6(1):e008859.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4716240</ArticleId><ArticleId IdType="pubmed">26743699</ArticleId></ArticleIdList></Reference><Reference><Citation>Bart SM, Cohen C, Dye JM, et al. Enhancement of Ebola virus infection by seminal amyloid fibrils. Proc Natl Acad Sci U S A. 2018. Jul 10;115(28):7410&#x2013;7415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6048544</ArticleId><ArticleId IdType="pubmed">29941593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirti S, Patel K, Das S, et al. Amyloid fibrils with positive charge enhance retroviral transduction in mammalian cells. ACS Bio Sci Eng. 2019. Jan 14;5(1):126&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">33405876</ArticleId></ArticleIdList></Reference><Reference><Citation>van Niel G, Carter DRF, Clayton DRF, et al. Challenges and directions in studying cell&#x2013;cell communication by extracellular vesicles. Nat Rev Mol Cell Biol. 2022. May 01;23(5):369&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">35260831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu M, Martin-Jaular L, Lavieu G, et al. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019. Jan;21(1):9&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">30602770</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangeot P-E, Dollet S, Girard M, et al. Protein transfer into human cells by VSV-G-induced nanovesicles. Mol Ther. 2011. Sep 01;19(9):1656&#x2013;1666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3182355</ArticleId><ArticleId IdType="pubmed">21750535</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer C, Losacco J, Stickney Z, et al. Pseudotyping exosomes for enhanced protein delivery in mammalian cells. Int J Nanomedicine. 2017. ;12:3153&#x2013;3170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5402897</ArticleId><ArticleId IdType="pubmed">28458537</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaillant A. HBsAg, subviral particles, and their clearance in establishing a functional cure of chronic hepatitis B virus infection. ACS Infect Dis. 2021. Jun 11;7(6):1351&#x2013;1368.</Citation><ArticleIdList><ArticleId IdType="pubmed">33302622</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Hossinger A, Heumuller SE, et al. Highly efficient intercellular spreading of protein misfolding mediated by viral ligand-receptor interactions. Nat Commun. 2021. Oct 19;12(1):5739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8526834</ArticleId><ArticleId IdType="pubmed">34667166</ArticleId></ArticleIdList></Reference><Reference><Citation>Geis FK, Goff SP. Silencing and transcriptional regulation of endogenous retroviruses: an overview. Viruses. 2020;12(8):884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472088</ArticleId><ArticleId IdType="pubmed">32823517</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;ry P, Nath A, Cr&#xe9;ange A, et al. Human endogenous retroviruses in neurological diseases. Trends Mol Med. 2018. Apr 01;24(4):379&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185488</ArticleId><ArticleId IdType="pubmed">29551251</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Heum&#xfc;ller S-E, Hossinger A, et al. Endogenous retroviruses promote prion-like spreading of proteopathic seeds. bioRxiv. 2022. May 06. 490866.</Citation></Reference><Reference><Citation>Stone PJ, Campistol JM, Abraham CR, et al. Neutrophil proteases associated with amyloid fibrils. Biochem Biophys Res Commun. 1993. Nov 30;197(1):130&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">8250917</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo EP, Guimaraes-Costa AB, Torezani GS, et al. Amyloid fibrils trigger the release of neutrophil extracellular traps (NETs), causing fibril fragmentation by NET-associated elastase. J Biol Chem. 2012. Oct 26;287(44):37206&#x2013;37218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3481320</ArticleId><ArticleId IdType="pubmed">22918834</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha N, Thakur AK. Likelihood of amyloid formation in COVID-19-induced ARDS. Trends Microbiol. 2021. Nov;29(11):967&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007089</ArticleId><ArticleId IdType="pubmed">33795156</ArticleId></ArticleIdList></Reference><Reference><Citation>Russe-Russe JR, Abramowitz C, Pellegrini JR, et al. COVID-19 exposure unmasking systemic amyloidosis with hepatic predominance. Cureus. 2022. Nov;14(11):e31092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9719725</ArticleId><ArticleId IdType="pubmed">36475164</ArticleId></ArticleIdList></Reference><Reference><Citation>Galkin AP. Hypothesis: aA amyloidosis is a factor causing systemic complications after coronavirus disease. Prion. 2021. Dec;15(1):53&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8078534</ArticleId><ArticleId IdType="pubmed">33876719</ArticleId></ArticleIdList></Reference><Reference><Citation>Menter T, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020. Aug;77(2):198&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7496150</ArticleId><ArticleId IdType="pubmed">32364264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bois MC, Boire NA, Layman AJ, et al. COVID-19-associated nonocclusive fibrin microthrombi in the heart. Circulation. 2021. Jan 19;143(3):230&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805556</ArticleId><ArticleId IdType="pubmed">33197204</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizurini DM, Hottz ED, Bozza PT, et al. Fundamentals in Covid-19-associated thrombosis: molecular and cellular aspects. Front Cardiovasc Med. 2021. ;8:785738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8718518</ArticleId><ArticleId IdType="pubmed">34977191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis E, Fine N, Miller RJH, et al. Amyloidosis and COVID-19: experience from an amyloid program in Canada. Ann Hematol. 2022. Oct;101(10):2307&#x2013;2315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417080</ArticleId><ArticleId IdType="pubmed">36028582</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee M, Pal R, Dutta S. Risk of incident diabetes post-COVID-19: a systematic review and meta-analysis. Prim Care Diabetes. 2022. Aug;16(4):591&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9148988</ArticleId><ArticleId IdType="pubmed">35654679</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022. Dec;612(7941):758&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022. Nov;28(11):2406&#x2013;2415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022. Apr;604(7907):697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Priemer DS, Rhodes CH, Karlovich E, et al. Abeta Deposits in the neocortex of adult and infant hypoxic brains, including in cases of COVID-19. J Neuropathol Exp Neurol. 2022. Nov 16;81(12):988&#x2013;995.</Citation><ArticleIdList><ArticleId IdType="pubmed">36264253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Davis PB, Volkow ND, et al. Association of COVID-19 with new-onset Alzheimer&#x2019;s Disease. J Alzheimers Dis. 2022;89(2):411&#x2013;414. DOI:10.3233/JAD-220717</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220717</ArticleId><ArticleId IdType="pmc">PMC10361652</ArticleId><ArticleId IdType="pubmed">35912749</ArticleId></ArticleIdList></Reference><Reference><Citation>Klug GM, Wand H, Simpson M, et al. Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol Neurosurg Psychiatry. 2013. Dec;84(12):1372&#x2013;1377.</Citation><ArticleIdList><ArticleId IdType="pubmed">23965290</ArticleId></ArticleIdList></Reference><Reference><Citation>Young MJ, O&#x2019;hare M, Matiello M, et al. Creutzfeldt-Jakob disease in a man with COVID-19: sARS-CoV-2-accelerated neurodegeneration? Brain Behav Immun. 2020. Oct;89:601&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362815</ArticleId><ArticleId IdType="pubmed">32681865</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayyebi G, Malakouti SK, Shariati B, et al. COVID-19-associated encephalitis or Creutzfeldt&#x2013;Jakob disease: a case report. Neurodegener Dis Manag. 2022. Feb;12(1):29&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8765092</ArticleId><ArticleId IdType="pubmed">34854312</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivo S, Furlanis G, Buoite Stella A, et al. Rapidly evolving Creutzfeldt-Jakob disease in COVID-19: from early status epilepticus to fatal outcome. Acta Neurol Belg. 2022. Jul 19:1&#x2013;4. doi10.1007/s13760-022-02023-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-022-02023-x</ArticleId><ArticleId IdType="pmc">PMC9294798</ArticleId><ArticleId IdType="pubmed">35852764</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardini A, Gigli GL, Janes F, et al. Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report. Prion. 2022. Dec;16(1):78&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9255144</ArticleId><ArticleId IdType="pubmed">35786166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciolac D, Racila R, Duarte C, et al. Clinical and radiological deterioration in a case of creutzfeldt-jakob disease following SARS-CoV-2 Infection: hints to accelerated age-dependent neurodegeneration. Biomedicines. 2021. Nov 19;9(11):1730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8615966</ArticleId><ArticleId IdType="pubmed">34829958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali SS, Mumtaz A, Qamar MA, et al. New-onset parkinsonism as a Covid-19 infection sequela: a systematic review and meta-analysis. Ann Med Surg (Lond). 2022. Aug;80:104281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9359766</ArticleId><ArticleId IdType="pubmed">35971509</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;rz M. A case report: multifocal necrotizing encephalitis and myocarditis after BNT162b2 mRNA vaccination against COVID-19. Vaccines. 2022;10(10):1651. [cited. 10.3390/vaccines10101651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101651</ArticleId><ArticleId IdType="pmc">PMC9611676</ArticleId><ArticleId IdType="pubmed">36298516</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Bedlack R. COVID-19-accelerated disease progression in two patients with amyotrophic lateral sclerosis. Muscle Nerve. 2021. Sep;64(3):E13&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441768</ArticleId><ArticleId IdType="pubmed">34131925</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology. 2000. Mar;20(1):8&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">10935432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner J, Degenhardt K, Veit M, et al. Medin co-aggregates with vascular amyloid-beta in Alzheimer&#x2019;s disease. Nature. 2022. Dec;612(7938):123&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9712113</ArticleId><ArticleId IdType="pubmed">36385530</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandrescu AT. Amyloid accomplices and enforcers. Protein Sci. 2005. Jan;14(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2253318</ArticleId><ArticleId IdType="pubmed">15576561</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive care Med. 2020. Jun;46(6):1089&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J. 2022. Feb 17;479(4):537&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Whyte CS, Simpson M, Morrow GB, et al. The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1. J Thromb Haemost. 2022. Oct;20(10):2394&#x2013;2406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349442</ArticleId><ArticleId IdType="pubmed">35780481</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammarstrom P. The bloody path of amyloids and prions. J Thromb Haemost. 2007. Jun;5(6):1136&#x2013;1138.</Citation><ArticleIdList><ArticleId IdType="pubmed">17567445</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumford AD, O&#x2019;donnell J, Gillmore JD, et al. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol. 2000. Aug;110(2):454&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">10971408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kos CA, Ward JE, Malek K, et al. Association of acquired von Willebrand syndrome with AL amyloidosis. Am J Hematol. 2007. May;82(5):363&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">17205535</ArticleId></ArticleIdList></Reference><Reference><Citation>Emori Y, Sakugawa M, Niiya K, et al. Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis. Blood Coagul Fibrinolysis. 2002. Sep;13(6):555&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">12192308</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouma B, Maas C, Hazenberg BP, et al. Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses. J Thromb Haemost. 2007. Jun;5(6):1139&#x2013;1142.</Citation><ArticleIdList><ArticleId IdType="pubmed">17371485</ArticleId></ArticleIdList></Reference><Reference><Citation>Reish NJ, Jamshidi P, Stamm B, et al. Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke. N Engl J Med. 2023. Jan 4;388(5):478&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10228637</ArticleId><ArticleId IdType="pubmed">36599061</ArticleId></ArticleIdList></Reference><Reference><Citation>Y-C S, Riesbeck K. Chapter 33 - Vitronectin. In: Barnum S, and Schein T, editors. The complement FactsBook. Second ed. Cambridge, Massachusetts, USA: Academic Press; 2018. pp. 351&#x2013;360.</Citation></Reference><Reference><Citation>Winter M, Tholey A, Kruger S, et al. MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits. J Histochem Cytochem. 2015. Oct;63(10):772&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4823803</ArticleId><ArticleId IdType="pubmed">26101327</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R, Xia C, Olejnik J, et al. Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells. Proc Natl Acad Sci U S A. 2022. Feb 8;119(6). doi :10.1073/pnas.2113874119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113874119</ArticleId><ArticleId IdType="pmc">PMC8833221</ArticleId><ArticleId IdType="pubmed">35078919</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocken C, Tautenhahn J, Buhling F, et al. Prevalence and pathology of amyloid in atherosclerotic arteries. Arterioscler Thromb Vasc Biol. 2006. Mar;26(3):676&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pubmed">16484604</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermark P, Mucchiano G, Marthin T, et al. Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am J Pathol. 1995. December 01;147(5):1186&#x2013;1192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1869500</ArticleId><ArticleId IdType="pubmed">7485381</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Ward LJ, Karlsson H, et al. Distinctive proteomic profiles among different regions of human carotid plaques in men and women. Sci Rep. 2016. May 20;6(1):26231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4873748</ArticleId><ArticleId IdType="pubmed">27198765</ArticleId></ArticleIdList></Reference><Reference><Citation>Stakhneva EM, Meshcheryakova IA, Demidov EA, et al. A proteomic study of atherosclerotic plaques in men with coronary atherosclerosis. Diagn (Basel). 2019. Nov 7;9(4):177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6963888</ArticleId><ArticleId IdType="pubmed">31703357</ArticleId></ArticleIdList></Reference><Reference><Citation>Das M, Gursky O. Amyloid-forming properties of human apolipoproteins: sequence analyses and structural insights. Adv Exp Med Biol. 2015;855:175&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5610898</ArticleId><ArticleId IdType="pubmed">26149931</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A, Vlok M, Turner S, et al. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabetol. 2022. Sep 21;21(1):190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, et al. Persistent clotting protein pathology in long COVID/Post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021. Aug 23;20(1):172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobel_Prize_Outreach . The nobel prize in physiology or medicine;1976.  [cited 2023 Mar
14]. Available from: https://www.nobelprize.org/prizes/medicine/1976/summary/</Citation></Reference><Reference><Citation>Guo W, Deguise J, Tian Y, et al. Profiling COVID-19 vaccine adverse events by statistical and ontological analysis of VAERS case reports [Original Research]. Front Pharmacol. 2022. Jun 24;13:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9263450</ArticleId><ArticleId IdType="pubmed">35814246</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraiman J, Erviti J, Jones M, et al. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 2022. Sep 22;40(40):5798&#x2013;5805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9428332</ArticleId><ArticleId IdType="pubmed">36055877</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>